Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

Author:

Fisher Cynthia L.12,Pineault Nicolas34,Brookes Christy1,Helgason Cheryl D.35,Ohta Hideaki36,Bodner Caroline3,Hess Jay L.7,Humphries R. Keith3,Brock Hugh W.1

Affiliation:

1. Department of Zoology, University of British Columbia, Vancouver, BC;

2. Wellcome Trust Sanger Institute, Cambridge, United Kingdom;

3. British Columbia Cancer Agency, Vancouver, BC;

4. Héma-Québec, Research and Development Department, Québec, QC;

5. Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, BC;

6. Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan; and

7. Department of Pathology, University of Michigan Ann Arbor

Abstract

AbstractThe Additional sex combs like 1 (Asxl1) gene is 1 of 3 mammalian homologs of the Additional sex combs (Asx) gene of Drosophila. Asx is unusual because it is required to maintain both activation and silencing of Hox genes in flies and mice. Asxl proteins are characterized by an amino terminal homology domain, by interaction domains for nuclear receptors, and by a C-terminal plant homeodomain protein-protein interaction domain. A recent study of patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) revealed a high incidence of truncation mutations that would delete the PHD domain of ASXL1. Here, we show that Asxl1 is expressed in all hematopoietic cell fractions analyzed. Asxl1 knockout mice exhibit defects in frequency of differentiation of lymphoid and myeloid progenitors, but not in multipotent progenitors. We do not detect effects on hematopoietic stem cells, or in peripheral blood. Notably, we do not detect severe myelodysplastic phenotypes or leukemia in this loss-of-function model. We conclude that Asxl1 is needed for normal hematopoiesis. The mild phenotypes observed may be because other Asxl genes have redundant function with Asxl1, or alternatively, MDS or oncogenic phenotypes may result from gain-of-function Asxl mutations caused by genomic amplification, gene fusion, or truncation of Asxl1.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 136 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Genomic alterations in blast phase of BCR::ABL1‐negative myeloproliferative neoplasms;International Journal of Laboratory Hematology;2023-10-22

2. Epigenetic regulation by ASXL1 in myeloid malignancies;International Journal of Hematology;2023-04-16

3. The etiology of clonal mosaicism in human aging and disease;Aging and Cancer;2023-02-17

4. Genomic Landscape and Risk Stratification of Acute Myeloid Leukemia;Pathogenesis and Treatment of Leukemia;2023

5. Epigenetic disorders: Lessons from the animals–animal models in chromatinopathies;Frontiers in Cell and Developmental Biology;2022-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3